Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Haematologica
|
March 10, 2018
Dexamethasone in hyperleukocytic acute myeloid leukemia
Sarah Bertoli, Muriel Picard, Emilie Bérard, et al.
Cancers
|
March 29, 2020
Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study
Sarah Bertoli, Pierre-Yves Dumas, Emilie Bérard, et al.
Genes, Chromosomes & Cancer
|
November 22, 2022
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance
Victor-Emmanuel Brett, Nicolas Lechevalier, Franck Trimoreau, et al.
Blood
|
May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
The Journal of Experimental Medicine
|
November 6, 2023
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL
Vincent Fregona, Manon Bayet, Mathieu Bouttier, et al.
Haematologica
|
August 27, 2013
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group
Sarah Bertoli, Pierre Bories, Marie C Béné, et al.
Blood Advances
|
August 14, 2020
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Blood Cancer Journal
|
May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study
Camille Gondran, Pierre-Yves Dumas, Emilie Bérard, et al.
Blood
|
January 17, 2013
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results
Nicole Dastugue, Stefan Suciu, Geneviève Plat, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Haematologica
|
March 10, 2018
Dexamethasone in hyperleukocytic acute myeloid leukemia
Sarah Bertoli, Muriel Picard, Emilie Bérard, et al.
Cancers
|
March 29, 2020
Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study
Sarah Bertoli, Pierre-Yves Dumas, Emilie Bérard, et al.
Genes, Chromosomes & Cancer
|
November 22, 2022
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance
Victor-Emmanuel Brett, Nicolas Lechevalier, Franck Trimoreau, et al.
Blood
|
May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
The Journal of Experimental Medicine
|
November 6, 2023
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL
Vincent Fregona, Manon Bayet, Mathieu Bouttier, et al.
Haematologica
|
August 27, 2013
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group
Sarah Bertoli, Pierre Bories, Marie C Béné, et al.
Blood Advances
|
August 14, 2020
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Blood Cancer Journal
|
May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study
Camille Gondran, Pierre-Yves Dumas, Emilie Bérard, et al.
Blood
|
January 17, 2013
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results
Nicole Dastugue, Stefan Suciu, Geneviève Plat, et al.
Page
of 7